TY - JOUR
T1 - Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients
AU - Castro, Mario
AU - Krowka, Michael J.
PY - 1996
Y1 - 1996
N2 - • Objective: To characterize the pulmonary hemodynamics and identify predictors of pulmonary hypertension in a group of patients before liver transplantation and to determine whether pulmonary hypertension in these patients is related to survival. • Material and Methods: In 362 patients before their first liver transplantation (between 1985 and 1993), the clinical history, laboratory data, and results of pulmonary function tests were recorded. Pulmonary artery (PA) catheterization was performed after induction of anesthesia at the time of transplantation. Monthly follow-up was maintained. • Results: A hyperdynamic circulation was often present-an increased mean cardiac output (7.6 L/ min), increased mean PA pressure (20.9 mm Hg), correlation of mean PA pressure with cardiac output (r - 0.25; P<0.001), and decreased mean pulmonary vascular resistance (60 dynes · s/cm5). Mean PA pressures were more than 25 mm Hg in 72 patients (20%). Pulmonary hypertension (defined as mean PA pressure of more than 25 mm Hg and pulmonary vascular resistance in excess of 120 dynes · s/cm5) occurred in 15 patients (4%). Pulmonary function tests revealed ob-struction in 7%, restriction in 18%, and low diffusing capacity in 46%. By univariate analysis, lower forced expiratory volume in 1 second, forced vital capacity, and total lung capacity were the only preoperative factors associated with pulmonary hypertension (P<0.05). Survival was significantly lower in patients with acute fulminant hepatitis (P<0.001), the group with the highest mean PA pressure, than in those with other diagnoses. Increased PA pressures or mild to moderate pulmonary hypertension was not found to be associated with a worse survival by univariate or multivariate analysis. • Conclusion: Increased PA pressure is common in liver transplant patients (20%). "True" pulmonary hypertension occurred in only 4% of our patients and was not associated with an adverse outcome.
AB - • Objective: To characterize the pulmonary hemodynamics and identify predictors of pulmonary hypertension in a group of patients before liver transplantation and to determine whether pulmonary hypertension in these patients is related to survival. • Material and Methods: In 362 patients before their first liver transplantation (between 1985 and 1993), the clinical history, laboratory data, and results of pulmonary function tests were recorded. Pulmonary artery (PA) catheterization was performed after induction of anesthesia at the time of transplantation. Monthly follow-up was maintained. • Results: A hyperdynamic circulation was often present-an increased mean cardiac output (7.6 L/ min), increased mean PA pressure (20.9 mm Hg), correlation of mean PA pressure with cardiac output (r - 0.25; P<0.001), and decreased mean pulmonary vascular resistance (60 dynes · s/cm5). Mean PA pressures were more than 25 mm Hg in 72 patients (20%). Pulmonary hypertension (defined as mean PA pressure of more than 25 mm Hg and pulmonary vascular resistance in excess of 120 dynes · s/cm5) occurred in 15 patients (4%). Pulmonary function tests revealed ob-struction in 7%, restriction in 18%, and low diffusing capacity in 46%. By univariate analysis, lower forced expiratory volume in 1 second, forced vital capacity, and total lung capacity were the only preoperative factors associated with pulmonary hypertension (P<0.05). Survival was significantly lower in patients with acute fulminant hepatitis (P<0.001), the group with the highest mean PA pressure, than in those with other diagnoses. Increased PA pressures or mild to moderate pulmonary hypertension was not found to be associated with a worse survival by univariate or multivariate analysis. • Conclusion: Increased PA pressure is common in liver transplant patients (20%). "True" pulmonary hypertension occurred in only 4% of our patients and was not associated with an adverse outcome.
UR - http://www.scopus.com/inward/record.url?scp=0030317077&partnerID=8YFLogxK
U2 - 10.4065/71.6.543
DO - 10.4065/71.6.543
M3 - Article
C2 - 8642882
AN - SCOPUS:0030317077
SN - 0025-6196
VL - 71
SP - 543
EP - 551
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 6
ER -